| 초록 |
Previous studies showed that in vitro exposure to biocompatible peritoneal dialysis (PD) solutions resulted in more
pronounced secretion of pro-inflammatory cytokines by peripheral blood mononuclear cells (PBMC) compared to
conventional glucose based lactate buffered solutions, and this observation was interpreted as improved host
defense status. In this study, we investigated whether such in vitro effects are reproduced in PD patients.
We enrolled 32 ESRD patients on maintenance PD as well as 10 healthy controls. Of those patients, 16 patients (PE-
N group) were using bicarbonate/lactate buffered glucose solutions (Physioneal 40, Baxter), amino acid solutions
(Nutrineal, Baxter) and icodextrin solutions (Extraneal, Baxter) and the other 16 patients (D-E group) were on lactate
buffered glucose solutions (Dianeal, Baxter) and icodextrin solutions. PBMC were isolated using Ficoll-Paque gradient
centrifugation, and then incubated with or without 100 ng/ml of lipopolysaccharide (LPS) for 24 h. Tumor necrosis
factor-α (TNF-α) and interleukin-6 (IL-6) proteins were measured. In addition, healthy volunteer PBMC (n=4) were
exposed to various PD solutions for 4 h and then incubated with 100 ng/ml LPS for 20 h to study the in vitro effect
of PD solutions.
The P-E-N group and the D-E group were similar in clinical and laboratory data including serum CRP and Kt/V (table
1). Serum TNF-α levels were comparable between the patient groups, but these levels were significantly higher than
the levels of controls (Fig. 1). Serum IL-6 levels were similar between two groups but the level of the D-E group
was significantly higher than that of controls (Fig 2). There was no significant difference in unstimulated TNF-α and
IL-6 levels, (Fig 3, 4) but, LPS stimulated TNF-α production was significantly higher in the D-E group compared to
the P-E-N group and controls (Fig 5). Similarly, LPS stimulated IL-6 production was higher in the D-E group compared
to the P-E-N group and controls (Fig 6). In vitro exposure of PBMC to PD solutions showed that exposure to Dianeal
1.36% did not lead to hyper-responsive secretion of TNF-α and IL-6 (Fig 7, 8).
PD patients on biocompatible PD solutions showed normal ex vivo function of PBMC in secreting pro-inflammatory
cytokines in response to LPS, whereas patients on lactate buffered solutions showed hyper-responsiveness to LPS
stimulation. In vitro exposure of PBMC to PD solutions showed discrepancies with ex vivo exposure results. |